A PHASE 1 CONCENTRATION-TARGETED MULTIDOSE STUDY OF ATEVIRDINE MESYLATE

甲磺酸阿特韦啶的 1 期浓度目标多剂量研究

• 批准号: 3761441
• 负责人: MICHAEL F PARA
• 金额: --
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3761441
• 关键词: 2'3' dideoxycytidine; 2'3' dideoxyinosine; AIDS therapy; HIV infections; antiAIDS agent; combination chemotherapy; dosage; drug screening /evaluation; human immunodeficiency virus; human subject; human therapy evaluation; pharmacokinetics; zidovudine

This protocol attempts to determine the pharmacokinetics of the triple drug combination of ZDV, ATV and dd1 or ddC in an effort to plan the feasibility of future clinical trails of the three drug combination in HIV-infected persons.

该方案试图确定三联制剂的药代动力学 ZDV、ATV和dd1或ddC的药物组合，以计划 三种药物联合应用的可行性 艾滋病毒感染者。